Celltrion
068270.KS
#679
Rank
NZ$64.61 B
Marketcap
NZ$283.37
Share price
-0.47%
Change (1 day)
33.55%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): NZ$4.93

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$5.82. In 2022 the company made an earnings per share (EPS) of NZ$5.20 a decrease over its 2021 EPS that were of NZ$6.18.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$4.93-5.21%
2022NZ$5.20-15.84%
2021NZ$6.1812.77%
2020NZ$5.4870.79%
2019NZ$3.2115.63%
2018NZ$2.78-33.13%
2017NZ$4.15141.17%
2016NZ$1.728.28%
2015NZ$1.5911.28%
2014NZ$1.4316.37%
2013NZ$1.23-67.42%
2012NZ$3.7784.22%
2011NZ$2.0562.13%
2010NZ$1.2680.61%
2009NZ$0.70-559.63%
2008NZ-$0.15-123.16%
2007NZ$0.66